Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The protein p27(Kip1) regulates cell cycle progression in mammals by inhibiting the activity of cyclin-dependent kinases (CDKs). Here we show that p27(Kip1) progressively accumulates in the nucleus of pancreatic beta cells in mice that lack either insulin receptor substrate 2 (Irs2(-/-)) or the long form of the leptin receptor (Lepr(-/-) or db/db). Deletion of the gene encoding p27(Kip1) (Cdkn1b) ameliorated hyperglycemia in these animal models of type 2 diabetes mellitus by increasing islet mass and maintaining compensatory hyperinsulinemia, effects that were attributable predominantly to stimulation of pancreatic beta-cell proliferation. Thus, p27(Kip1) contributes to beta-cell failure during the development of type 2 diabetes in Irs2(-/-) and Lepr(-/-) mice and represents a potential new target for the treatment of this condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cell cycle inhibitor p27, a marker of senescence, increases in pancreatic β-cells in genetic mouse models of type 2 diabetes, and p27 deletion in those mice increased insulin secretion and islet mass through increased proliferation (64).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [64]
In the citing paper
“For instance, when cell cycle arrest is induced specifically in β-cells by overexpression of p27 [24] or by deletion of Cdk4 postnatally, β-cell mass decreases or fails to expand, which would not be the case if neogenesis or transdifferentiation were major sources of new β-cells [25,26].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [24]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594 · cited 1×
“This effect of Akt is mediated by the transcriptional regulator Foxo1 (refs”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“The mass of pancreatic islets is also reduced in individuals with this conditio”
BackgroundA mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Abnormal splicing of the leptin receptor in diabetic mice
Lee, G.-H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996) · Nature · doi:10.1038/379632a0 · Cited by 2,327 · cited 1×
“These mice develop obesity because of hyperphagia, decreased energy expenditure and preferential partitioning of calories into adipose tissue triglyceride”
BackgroundChen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817 · cited 1×
“, resulting in its degradation by the ubiquitin-proteasome pathwa”
BackgroundDisruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775 · cited 1×
“Irs2-deficient ( Irs2 −/− ) mice do not maintain islet mass in the face of hepatic insulin resistanc”
BackgroundSelf-citationNakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Self-citation
Cited by
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744
p16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Thrailkill, K. M., Lumpkin, C. K., Bunn, R. C., Kemp, S. F., & Fowlkes, J. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00159.2005 · Cited by 490
“How insulin signaling might promote osteoblastogenesis is speculative; however, studies examining pancreatic -cells suggests a direct action of insulin to inactivate p27, a cyclin-dependent kinase inhibitor that could attenuate cell proliferation in osteoblasts (128).”
BackgroundAge-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk
Chia, C. W., Egan, J. M., & Ferrucci, L. (2018) · Circulation Research · doi:10.1161/circresaha.118.312806 · Cited by 454
“Deletion of p27 seemed to enhance insulin secretion because of increased number of β-cell proliferation.(136) However, a recent study showed that in healthy old mice and healthy humans, p16-induced senescence of β cells resulted in enhanced insulin secretion compared with β cells from young animals in response to high…”
ResultRETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
“On the contrary, cell-cycle inhibitors, including p15 Ink4b , p18 Ink4c , and p27 Kip1 , repress b cell replication (Latres et al., 2000; Pei et al., 2004; Uchida et al., 2005).”
BackgroundRetractedCellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
“The cell cycle inhibitor p27, a marker of senescence, increases in pancreatic b-cells in genetic mouse models of type 2 diabetes, and p27 deletion in those mice increased insulin secretion and islet mass through increased proliferation (64).”
BackgroundInsulin resistance and pancreatic cell failure
Kasuga, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29189 · Cited by 412
Self-citationRedox Control of the Cell Cycle in Health and Disease
Sarsour, E. H., Kumar, M. G., Chaudhuri, L., Kalen, A. L., & Goswami, P. C. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2513 · Cited by 381
“p27-Knockout mice showed increased b-cell proliferation and suppressed hyperglycemia, whereas p27 overexpression resulted in severe diabetes (329).”
Expansion of β-cell mass in response to pregnancy
Rieck, S., & Kaestner, K. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.001 · Cited by 358
“For instance, when cell cycle arrest is induced specifically in β-cells by overexpression of p27 [24] or by deletion of Cdk4 postnatally, β-cell mass decreases or fails to expand, which would not be the case if neogenesis or transdifferentiation were major sources of new β-cells [25,26].”
BackgroundCyclins D2 and D1 Are Essential for Postnatal Pancreatic β-Cell Growth
Kushner, J. A., Ciemerych, M. A., Sicinska, E., Wartschow, L. M., Teta, M., Long, S. Y., Sicinski, P., & White, M. F. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3752-3762.2005 · Cited by 334
Self-citationThe replication of β cells in normal physiology, in disease and for therapy
Butler, P. C., Meier, J. J., Butler, A. E., & Bhushan, A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0647 · Cited by 268
“Deletion of a member of the Cip/Kip family, p27Kip1 (p27; cyclin-dependent kinase inhibitor 1B) ameliorated hyperglycemia in animal models of type 2 diabetes, suggesting that p27 represents a potential new target for treatment of diabetes”
BackgroundMolecular regulation of pancreatic β-cell mass development, maintenance, and expansion
Ackermann, A. M., & Gannon, M. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-06-0053 · Cited by 262
“Transgenic Journal of Molecular Endocrinology (2007) 38, 193–206 overexpression of p27Kip1 within b-cells using the rat insulin promoter (Rip-p27Kip1) impairs b-cell proliferation, resulting in decreased b-cell mass and diabetes in mice (Uchida et al. 2005).”
BackgroundInfluentialYamada, T., Ishihara, H., Tamura, A., Takahashi, R., Yamaguchi, S., Takei, D., Tokita, A., Satake, C., Tashiro, F., Katagiri, H., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl081 · Cited by 251
“Furthermore, reduced proliferation associated with increased expression of p21, in wfs1-deficient b-cells (the present study) and b-cells transgenic for hepatocyte growth factor and/or placental lactogen (35), highlights an important role for p21 in regulation of b-cell mass in addition to the roles of p27 recently re…”
BackgroundMorioka, T., Asilmaz, E., Hu, J., Dishinger, J. F., Kurpad, A. J., Elias, C. F., Li, H., Elmquist, J. K., Kennedy, R. T., & Kulkarni, R. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30910 · Cited by 247
“Similarly, the islet hyperplasia observed in mice bearing defects in the leptin (ob/ob) or the ObR (db/db) gene is likely due, in part, to deficient leptin signaling and consequent enhanced insulin action in β cells (7, 37).”
BackgroundOxidative Stress in Pancreatic Beta Cell Regeneration
Wang, J., & Wang, H. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1930261 · Cited by 233
“Overexpression of p27 in β cells causes hyperglycemia by four weeks of age and markedly reduced islet mass by 8 weeks of age [48].”
BackgroundAblation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass
Hashimoto, N., Kido, Y., Uchida, T., Asahara, S.-I., Shigeyama, Y., Matsuda, T., Takeda, A., Tsuchihashi, D., Nishizawa, A., Ogawa, W., et al. (2006) · Nature Genetics · doi:10.1038/ng1774 · Cited by 227
“We recently showed that the cyclin-dependent kinase inhibitor p27 Kip1 contributes to the regulation of β cell mass and that its expression in β cells is controlled, at least in part, by Ak”
BackgroundSelf-citationβ-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
“In addition, b-cells from db/db mice exhibit increased p27 levels and deletion of this inhibitor protein rescues the diabetes from mice deficient in IRS2, indicating that p27 is part of the abnormal adaptation of b-cells to insulin resistance [20].”
The role of FOXO1 in β-cell failure and type 2 diabetes mellitus
Kitamura, T. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.157 · Cited by 221
All β Cells Contribute Equally to Islet Growth and Maintenance
Brennand, K., Huangfu, D., & Melton, D. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050163 · Cited by 210
“Furthermore, the forced cell cycle arrest of b cells severely restricts postnatal b cell mass [13], indicating that non–b cells (such as putative adult stem cells) cannot maintain b cell mass.”
BackgroundPapatheodoridi, A., Chrysavgis, L., Koutsilieris, M., & Chatzigeorgiou, A. (2020) · Hepatology · doi:10.1002/hep.30834 · Cited by 209
“Deletion of p27 in Irs2-deficient or db/db diabetic mice improved hyperglycemia by inducing compensatory insulin production as a result of improved maintenance of their islet mass.(27) Besides, senescent endothelial cells express p16INK4a and SA-β-GAL at atherosclerotic plaques, and gene polymorphisms in p21 affect th…”
BackgroundDiabetes mellitus—advances and challenges in human β-cell proliferation
Wang, P., Fiaschi-Taesch, N. M., Vasavada, R. C., Scott, D. K., García-Ocaña, A., & Stewart, A. F. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.9 · Cited by 205
Molecular Control of Cell Cycle Progression in the Pancreatic β-Cell
Cozar-Castellano, I., Fiaschi-Taesch, N., Bigatel, T. A., Takane, K. K., Garcia-Ocaña, A., Vasavada, R., & Stewart, A. F. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0004 · Cited by 198
Diabetes and Insulin in Regulation of Brain Cholesterol Metabolism
Suzuki, R., Lee, K., Jing, E., Biddinger, S. B., McDonald, J. G., Montine, T. J., Craft, S., & Kahn, C. R. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.006 · Cited by 169
“…mice, an autoimmune model of type 1 diabetes (Figure 2A), and hypothalami from obese, insulin-resistant db/dbmice on aC57Bl/Ks background (Figure 2B), which exhibit a combination of obesity, insulin resistance, and declining insulin levels due to progressive b-cell failure (Uchida et al., 2005).”
Biphasic Response of Pancreatic β-Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice
Shigeyama, Y., Kobayashi, T., Kido, Y., Hashimoto, N., Asahara, S.-I., Matsuda, T., Takeda, A., Inoue, T., Shibutani, Y., Koyanagi, M., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01695-07 · Cited by 177
“Lysates of isolated islets that had been stimulated (or not) with 100 nM recombinant human IGF-1 (Pepro Tech) were prepared as previously described (14, 27 ).”
MethodSelf-citationIntrinsic Regulators of Pancreatic β-Cell Proliferation
Heit, J. J., Karnik, S. K., & Kim, S. K. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104425 · Cited by 165
Sachdeva, M. M., & Stoffers, D. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0400 · Cited by 158
Pancreatic β-Cell Proliferation in Obesity
Linnemann, A. K., Baan, M., & Davis, D. B. (2014) · Advances in Nutrition · doi:10.3945/an.113.005488 · Cited by 132
“Interestingly, p27 knockout mice have increased islet proliferation when made genetically obese or when fed a high-fat diet, whereas p27 overexpression in these scenarios reduces b-cell proliferation (68).”
BackgroundFiaschi‐Taesch, N., Salim, F. G., Kleinberger, J. W., Troxell, R., Cózar‐Castellano, I., Selk, K. L., Cherok, E., Takane, K. K., Scott, D. K., & Stewart, A. F. (2010) · Diabetes · doi:10.2337/db09-1776 · Cited by 155
The FoxM1 Transcription Factor Is Required to Maintain Pancreatic β-Cell Mass
Zhang, H., Ackermann, A. M., Gusarova, G. A., Lowe, D., Feng, X., Kopsombut, U. G., Costa, R. H., & Gannon, M. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0056 · Cited by 134
Growth factors and beta cell replication
Vasavada, R. C., Gonzalez-Pertusa, J. A., Fujinaka, Y., Fiaschi-Taesch, N., Cozar-Castellano, I., & Garcia-Ocaña, A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.003 · Cited by 133
Effects of leptin and adiponectin on pancreatic β-cell function
Lee, Y., Magkos, F., Mantzoros, C. S., & Kang, E. S. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.008 · Cited by 152
“[29] Uchida T, Nakamura T, Hashimoto N, et al.”
BackgroundThe CDK4–pRB–E2F1 pathway controls insulin secretion
Annicotte, J., Blanchet, É., Chavey, C., Iankova, I., Costes, S., Assou, S., Teyssier, J., Dalle, S., Sardet, C., & Fajas, L. (2009) · Nature Cell Biology · doi:10.1038/ncb1915 · Cited by 160
Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells
Kim, W., Doyle, M. E., Liu, Z., Lao, Q., Shin, Y., Carlson, O. D., Kim, H. S., Thomas, S., Napora, J. K., Lee, E. K., et al. (2011) · Diabetes · doi:10.2337/db10-1550 · Cited by 136
“Given that AKT regulates p27 (p27) activity, an inhibitor of cell cycle progression, by affecting its abundance and subcellular localization (31,32), and that accumulation of p27 in the nuclei of b-cells contributes to deficient b-cell mass and proliferation during the development of type 2 diabetes in Irs2 and db/db…”
BackgroundSmart, N. G., Apelqvist, Å., Gu, X., Harmon, E. B., Topper, J. N., MacDonald, R. J., & Kim, S. K. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040039 · Cited by 126
Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice
Xiong, W.-T., Gu, L., Wang, C., Sun, H., & Liu, X. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.09.027 · Cited by 120
Fiaschi-Taesch, N., Bigatel, T. A., Sicari, B., Takane, K. K., Salim, F., Velazquez-Garcia, S., Harb, G., Selk, K., Cozar-Castellano, I., & Stewart, A. F. (2009) · Diabetes · doi:10.2337/db08-0631 · Cited by 117
“This human islet transplant model is important, because it will permit investigators to ask for the first time, using human islets, whether interventions such as glucose infusion (37), dietinduced obesity (20), lipid infusion (38), pregnancy (27), or treatment with growth factors or drugs such as GLP-1, exenatide, gas…”
BackgroundTanabe, K., Liu, Z., Patel, S., Doble, B. W., Li, L., Cras-Méneur, C., Martinez, S. C., Welling, C. M., White, M. F., Bernal-Mizrachi, E., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060037 · Cited by 115
“by reduced Akt activity in islets [40].”
BackgroundInfluentialSelf-citationMatsuda, T., Kido, Y., Asahara, S., Kaisho, T., Tanaka, T., Hashimoto, N., Shigeyama, Y., Takeda, A., Inoue, T., Shibutani, Y., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39721 · Cited by 122
Self-citationRomero-Díaz, C., Duarte‐Montero, D., Gutiérrez-Romero, S. A., & Mendivil, C. O. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00964-1 · Cited by 118
Deconstructing Pancreas Developmental Biology
Benitez, C. M., Goodyer, W. R., & Kim, S. K. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012401 · Cited by 102
“2005), CDK inhibitors (CKIs) (Uchida et al. 2005; Chen et al. 2009), the transcription factor FoxM1 (Zhang et al.”
BackgroundAguilar, V. M., & Fajas, L. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000089 · Cited by 119
Two-way communication between the metabolic and cell cycle machineries: the molecular basis
Kaplon, J., van Dam, L., & Peeper, D. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1044172 · Cited by 99
Zhong, L., Georgia, S., Tschen, S.-I., Nakayama, K., Nakayama, K., & Bhushan, A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32198 · Cited by 92
Self-citationHamada, S., Hara, K., Hamada, T., Yasuda, H., Moriyama, H., Nakayama, R., Nagata, M., & Yokono, K. (2009) · Diabetes · doi:10.2337/db08-0519 · Cited by 97
“A similar phenotype has been reported for the downregulation of more distal negative mediators of Akt, FoxO1, and p27 (15,16,45).”
BackgroundAkt and PTEN: β-cell mass and pancreas plasticity
Elghazi, L., & Bernal‐Mizrachi, E. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.03.002 · Cited by 98
p27 Regulates the Transition of β-Cells From Quiescence to Proliferation
Georgia, S. K., & Bhushan, A. (2006) · Diabetes · doi:10.2337/db06-0249 · Cited by 102
“The major mechanism for regulating p27 levels is thought to be posttranslational proteolytic degradation, as the mRNA levels of p27 are constant throughout the cell cycle (18,19).”
BackgroundCannabinoids Induce Pancreatic β-Cell Death by Directly Inhibiting Insulin Receptor Activation
Kim, W., Lao, Q., Shin, Y., Carlson, O. D., Lee, E. K., Gorospe, M., Kulkarni, R., & Egan, J. M. (2012) · Science Signaling · doi:10.1126/scisignal.2002519 · Cited by 104
Cózar‐Castellano, I., Weinstock, M. T., Haught, M., Velázquez-García, S., Sipula, D., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0632 · Cited by 98
Interventions for age-related diseases: Shifting the paradigm
Figueira, I., Fernandes, A., Mladenovic Djordjevic, A., Lopez-Contreras, A., Henriques, C. M., Selman, C., Ferreiro, E., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 87
Inoue, N., Yahagi, N., Yamamoto, T., Ishikawa, M., Watanabe, K., Matsuzaka, T., Nakagawa, Y., Takeuchi, Y., Kobayashi, K., Takahashi, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801824200 · Cited by 87
Exendin-4 Stimulation of Cyclin A2 in β-Cell Proliferation
Song, W., Schreiber, W. E., Zhong, E., Liu, F., Kornfeld, B. D., Wondisford, F. E., & Hussain, M. A. (2008) · Diabetes · doi:10.2337/db07-1541 · Cited by 102
“2), consistent with observations that -cell p27 increases with age, which prevents -cell expansion (17).”
Crawford, L. A., Guney, M. A., Oh, Y. A., DeYoung, R. A., Valenzuela, D. M., Murphy, A. J., Yancopoulos, G. D., Lyons, K. M., Brigstock, D. R., Economides, A. N., et al. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0045 · Cited by 92
Perera, C. N., Chin, H. G., Duru, N., & Camarillo, I. G. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0215 · Cited by 81
Skp2 Controls Adipocyte Proliferation during the Development of Obesity
Sakai, T., Sakaue, H., Nakamura, T., Okada, M., Matsuki, Y., Watanabe, E., Hiramatsu, R., Nakayama, K., Nakayama, K. I., & Kasuga, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608144200 · Cited by 80
Self-citationEmerging role of protein kinase B/Akt signaling in pancreatic β-cell mass and function
Elghazi, L., Balcázar, N., & Bernal‐Mizrachi, E. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.08.017 · Cited by 105
Pascoe, J. L., Hollern, D. A., Stamateris, R. E., Abbasi, M., Romano, L. C., Zou, B., O'Donnell, C. P., García-Ocaña, A., & Alonso, L. C. (2012) · Diabetes · doi:10.2337/db11-0991 · Cited by 87
Iwashita, N., Uchida, T., Choi, J. B., Azuma, K., Ogihara, T., Ferrara, N., Gerber, H., Kawamori, R., Inoue, M., & Watada, H. (2006) · Diabetologia · doi:10.1007/s00125-006-0512-0 · Cited by 76
“Apart from the direct effect via disturbed VEGFA signalling, recent data suggest that an autocrine effect of insulin through insulin receptor/phosphatidylinositol-3 kinase signalling pathways mediates beta cell function [26–30].”
BackgroundSelf-citationMeng, Z.-X., Nie, J., Ling, J.-J., Sun, J.-X., Zhu, Y.-X., Gao, L., Lv, J., Zhu, D.-Y., Sun, Y.-J., & Han, X. (2008) · Diabetologia · doi:10.1007/s00125-008-1174-x · Cited by 72
“Previous studies have shown that the p27 levels within beta cells plays an essential role in translating metabolic demands or other environmental treatments into regulation of beta cell mass, but has no obvious effect under normal physiological conditions [8, 9].”
InfluentialGrowth factor control of pancreatic islet regeneration and function
Aßmann, A., Hinault, C., & Kulkarni, R. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00468.x · Cited by 78
“While global knockout mice for p27kip1 exhibit no phenotype on postnatal b-cell expansion (81), b-cell-specific overexpression of p27kip1 leads to islet hypoplasia and diabetes (81).”
BackgroundGeorgia, S. K., Hinault, C., Kawamori, D., Hu, J., Meyer, J., Kanji, M., Bhushan, A., & Kulkarni, R. N. (2010) · Diabetes · doi:10.2337/db09-0838 · Cited by 73
Cyclin D2 Translocates p27 out of the Nucleus and Promotes Its Degradation at the G0-G1 Transition
Susaki, E. A., Nakayama, K., & Nakayama, K. I. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00862-06 · Cited by 79
“In addition to lymphocytes, the ovaries, testes, and pancreas manifest phenotypes in cyclin D2-deficient mice (42, 72) that appear opposite to those in p27-deficient mice (23, 37, 58, 78).”
BackgroundSelf-citationRole of TGF-Beta Signaling in Beta Cell Proliferation and Function in Diabetes
Wang, H., Wang, L., Zhao, C.-Y., & Lan, H. Y. (2022) · Biomolecules · doi:10.3390/biom12030373 · Cited by 74
Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes
Taneera, J., Fadista, J., Ahlqvist, E., Zhang, M., Wierup, N., Renström, E., & Groop, L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.05.003 · Cited by 65
Elghazi, L., Balcázar, N., Blandino-Rosano, M., CRAS-MÉNEUR, C. M. H., Fátrai, S., Gould, A. P., Chi, M. M.-Y., Moley, K. H., & Bernal‐Mizrachi, E. (2010) · Diabetes · doi:10.2337/db09-0851 · Cited by 69
“The importance of p27 in regulation of the -cell cycle in our model resembles the findings obtained in islets from models of diet-induced obesity and suggests that S6K signaling may be implicated in the -cell failure observed in this model (34).”
BackgroundResultCell cycle control of β-cell replication in the prenatal and postnatal human pancreas
Köhler, C. U., Olewinski, M., Tannapfel, A., Schmidt, W. E., Fritsch, H., & Meier, J. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00496.2010 · Cited by 63
“In line with this, p27 overexpression has led to the development of overt diabetes in mice (49), and p27 knockout animals exhibited an 2-fold increase in -cell mass (20).”
BackgroundVagal control of pancreatic β-cell proliferation
Lausier, J., Diaz, W. C., Roskens, V. A., LaRock, K., Herzer, K., Fong, C. G., Latour, M. G., Peshavaria, M., & Jetton, T. L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00202.2010 · Cited by 63
“Akt kinase in particular has been ascribed a central role in -cell proliferation through activating cell cycle progression through cyclin D2 (2) and its inhibition of the cell cycle inhibitor p27 (45).”
BackgroundTavana, O., Puebla-Osorio, N., Sang, M., & Zhu, C. (2010) · Diabetes · doi:10.2337/db09-0792 · Cited by 58
“Overexpression of p16 (36) or p27 (37) leads to a decrease in -cell proliferation rate and reduction in -cell mass.”
BackgroundFontanière, S., Tost, J., Wierinckx, A., Lachuer, J., Lu, J., Hussein, N., Busato, F., Gut, I. G., Wang, Z.-Q., & Zhang, C. X. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01294 · Cited by 58
Emerging role of protein kinase B/Akt signaling in pancreatic β-cell mass and function
Elghazi, L., Balcázar, N., & Bernal‐Mizrachi, E. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.01.005 · Cited by 63
Destruction of Pancreatic β-Cells by Transgenic Induction of Prostaglandin E2 in the Islets
Oshima, H., Taketo, M. M., & Oshima, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602424200 · Cited by 52
Regulation of beta cell replication
Lee, Y. C., & Nielsen, J. H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.033 · Cited by 63
Agudo, J., Ayuso, E., Jiménez, V., Salavert, A., Casellas, A., Tafuro, S., Haurigot, V., Ruberte, J., Segovia, J. C., Bueren, J. A., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1087-8 · Cited by 54
“Recent studies have implicated the insulin and IGF-I signalling pathways in the regulation of beta cell proliferation [16, 17].”
BackgroundLi, J., Wang, W., Fan, C., Wang, M., Zhang, X., Hu, Q.-H., & Kong, L. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/303902 · Cited by 73
RetractedRachdi, L., Balcazar, N., Elghazi, L., Barker, D. J., Krits, I., Kiyokawa, H., & Bernal-Mizrachi, E. (2006) · Diabetes · doi:10.2337/db06-0861 · Cited by 51
“Recent studies showed that p27 deficiency prevented the development of overt hyperglycemia in both Irs2 / and Lepr / mice by increased islet mass and serum insulin concentration (12).”
BackgroundMethodInfluentialReversal of preexisting hyperglycemia in diabetic mice by acute deletion of the Men1 gene
Yang, Y., Gurung, B., Wu, T., Wang, H., Stoffers, D. A., & Hua, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012257107 · Cited by 53
“Conventional gene targeting mouse models, such as the knockout models for D-cyclins and p27, were used to evaluate the impact of gene ablation on the prevention of diabetes (2, 3).”
BackgroundMethodKim, S. Y., & Rane, S. G. (2011) · Development · doi:10.1242/dev.061481 · Cited by 58
“In addition, several recent studies have underscored the important roles of other cell cycle regulators in cell biology (Annicotte et al., 2009; Cozar-Castellano et al., 2006; Fajas et al., 2004; Fiaschi-Taesch et al., 2009; Georgia and Bhushan, 2004; Georgia and Bhushan, 2006; Georgia et al., 2010; Georgia et al.,…”
Insulin secretion and insulin-producing tumors
Guettier, J., & Görden, P. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.83 · Cited by 55
Cozar-Castellano, I., Haught, M., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/db06-0627 · Cited by 47
“Moreover, we have learned that removal of a single inhibitor (specific examples are pRb [35–37], p53 [35,36], p18 [29], p27 [7,29], and now p21) has little effect on the restraint of cell cycle control.”
BackgroundThe regulation of pre- and post-maturational plasticity of mammalian islet cell mass
Mezza, T., & Kulkarni, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3251-7 · Cited by 48
“overexpression of the inhibitor p27 [59] in beta cells impairs proliferation, resulting in reduced beta cell mass.”
BackgroundThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
New sources of pancreatic beta cells
Porat, S., & Dor, Y. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0049-8 · Cited by 45
“For example, transgenic expression of the cyclin kinase inhibitor p27 specifi cally inC cells leads to a failure of C-cell mass, attesting to the importance of C-cell proliferation; if stem cells were capable of generating significa nt numbers of C cells, blocking the proliferation of differentiatedC cells should have…”
BackgroundmTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function
Yuan, T., Lupše, B., Maedler, K., & Ardestani, A. D. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.013 · Cited by 51
Zhao, L., Su, J., Li, L., Chen, J., Hu, S., Zhang, X., & Chen, T. (2014) · Food Research International · doi:10.1016/j.foodres.2014.08.051 · Cited by 44
Puff, R., Dames, P., Weise, M., Göke, B., Seißler, J., Parhofer, K. G., & Lechner, A. (2011) · Hormone and Metabolic Research · doi:10.1055/s-0031-1271817 · Cited by 42
Tian, N., Chen, D., Han, H., Jin, J., & Li, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-54192-9 · Cited by 47
Targeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2
Oliveira, J. M., Rebuffat, S. A., Gasa, R., & Gomis, R. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0114 · Cited by 43
“2002); deletion of p27Kip1 (regulates cell cycle progression by inhibiting the activity of cyclin-dependent kinases) increased islet mass owing to increased proliferation, which prevented the development of overt hyperglycemia in Irs2−/− mice (Uchida et al. 2005); or upregulation of Pdx1 restored beta-cell mass and fu…”
Backgroundβ-cell regeneration: Neogenesis, replication or both?
Levine, F., & Itkin‐Ansari, P. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0259-1 · Cited by 49
“Rather, p27Kip1 is present at high levels in murine β-cells [59], and Kip1 deletion results in β-cell hyperplasia [59].”
BackgroundDyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass
Rachdi, L., Kariyawasam, D., Guez, F., Aïello, V., Arbonés, M. L., Janel, N., Delabar, J. M., Polak, M., & Scharfmann, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3174-3 · Cited by 44
β-cell proliferation is the major source of new pancreatic β cells
Dor, Y. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0187 · Cited by 38
“Transgenic expression of the cyclin-dependent kinase inhibitor p27 blocks β-cell proliferation, resulting in a greatly reduced postnatal β-cell mass and causing diabetes”
BackgroundMore, V. R., Wen, X., Thomas, P. E., Aleksunes, L. M., & Slitt, A. L. (2012) · Comparative Hepatology · doi:10.1186/1476-5926-11-1 · Cited by 38
“morphology [11-13].”
A Simple Matter of Life and Death—The Trials of Postnatal Beta-Cell Mass Regulation
Tarabra, E., Pelengaris, S., & Khan, M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/516718 · Cited by 40
“Overexpression of p27 in beta-cells of transgenic mice impairs beta-cell proliferation, resulting in decreased beta-cell mass and diabetes [195].”
BackgroundWeighing up β-cell mass in mice and humans: Self-renewal, progenitors or stem cells?
Hanley, N. A., Hanley, K. P., Miettinen, P. J., & Otonkoski, T. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.03.001 · Cited by 40
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J., Rayner, N. W., Steinthórsdóttir, V., Scott, R. A., Grarup, N., Cook, J. P., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/245506 · Cited by 37
Prevention of Diabetes in db/db Mice by Dietary Soy Is Independent of Isoflavone Levels
Zimmermann, C., Cederroth, C. R., Bourgoin, L., Foti, M., & Nef, S. (2012) · Endocrinology · doi:10.1210/en.2012-1490 · Cited by 38
Chirivella, L., Kirstein, M., Ferrón, S. R., Domingo-Muelas, A., Durupt, F. C., Umanzor, C. A., Cano‐Jaimez, M., Pérez‐Sánchez, F., Barbacid, M., Ortega, S., et al. (2017) · Stem Cells · doi:10.1002/stem.2694 · Cited by 39
How to make pancreatic β cells — prospects for cell therapy in diabetes
Nir, T., & Dor, Y. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.07.005 · Cited by 36
Lock, L. T., Laychock, S. G., & Tzanakakis, E. S. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.12.015 · Cited by 35
“Similarly, the cyclin-dependent kinase inhibitors (CDKIs) p21 and p27, which are important -cell cycle regulators (Cozar-Castellano et al., 2006b; Uchida et al., 2005), were also expressed at similar levels in PIs from bioreactors and dishes.”
BackgroundComstock, S. M., Pound, L. D., Bishop, J. M., Takahashi, D. L., Kostrba, A. M., Smith, M. S., & Grove, K. L. (2012) · Molecular Metabolism · doi:10.1016/j.molmet.2012.11.001 · Cited by 38
“Total islet area (insulin and glucagon stained area/DAPI stained area), islet mass (total islet area pancreas weight), b and a cell mass [(total insulin or glucagon stained area/DAPI stained area)pancreas weight], and islet density (total islet number/DAPI area) were calculated as previously reported [27].”
MethodLee, J.-H., Jo, J., Hardikar, A. A., Periwal, V., & Rane, S. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008653 · Cited by 41
“Several recent studies have underscored the important roles of other cell cycle regulators in b-cell biology [37,38,39,40,41,42,43].”
BackgroundmPGES-2 blockade antagonizes β-cell senescence to ameliorate diabetes by acting on NR4A1
Zhong, D., Wan, Z., Cai, J., Quan, L., Zhang, R., Teng, T., Gao, H., Fan, C., Wang, M., Guo, D. M., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00536-6 · Cited by 35
Metadata
- Authors
- Uchida, T., Nakamura, T., Hashimoto, N., Matsuda, T., Kotani, K., Sakaue, H., Kido, Y., Hayashi, Y., Nakayama, K. I., White, M. F., & Kasuga, M.
- Affiliations
- Kobe University (JP)
- Kyushu University (JP)
- Joslin Diabetes Center (US)
- Corresponding author
- Kasuga, Masato
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-01-30
- Volume
- 11
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151058113
- Cited by
- 218
- References
- 48
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 4 · 2019: 4 · 2018: 9 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 8 · 2013: 9 · 2012: 13
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- p27, type 2 diabetes, hyperglycemia, compensatory hyperinsulinemia, pancreatic beta cells, beta-cell proliferation, beta-cell failure, insulin receptor substrate 2, leptin receptor, db/db mice, islet mass, cyclin-dependent kinase inhibition
- MeSH terms
- Animals, Cell Nucleus, Diabetes Mellitus, Type 2, Disease Models, Animal, Enzyme Inhibitors, Hyperglycemia, Hyperinsulinism, Insulin-Like Growth Factor I, Islets of Langerhans, Phosphoproteins, Proto-Oncogene Proteins, Receptors, Cell Surface, Signal Transduction, Protein Serine-Threonine Kinases, Mice, Knockout, Cell Cycle Proteins, Leptin, Tumor Suppressor Proteins, Intracellular Signaling Peptides and Proteins, Cyclin-Dependent Kinase Inhibitor p27, Proto-Oncogene Proteins c-akt, Mice, Receptors, Leptin, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.